Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-02 Sale |
2024-12-02 7:50 pm |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
2,500 | $49 | $122,500 | 29,127 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-17 6:20 pm |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
13,500 | $48.28 | $651,766 | 38,627 (Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 9:02 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,658 | $20.01 | $113,214 | 435,802 (Direct) |
View |
| 2023-08-22 Sale |
2023-08-24 8:30 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
18,600 | $20.01 | $372,186 | 390,877 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-15 8:30 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
1,400 | $20 | $28,000 | 368,727 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-11 9:00 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
20,000 | $21.58 | $431,541 | 410,877 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:31 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,966 | $18.05 | $107,686 | 263,436 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 8:01 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $25.03 | $375,450 | 265,605 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 7:03 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
3,507 | $14.59 | $51,167 | 229,402 (Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 9:01 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
30,000 | $35.08 | $1,052,322 | 327,459 (Direct) |
View |
| 2021-07-20 Sale |
2021-07-22 9:01 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
17,400 | $33.14 | $576,575 | 325,103 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-19 9:02 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
4,600 | $33.37 | $153,502 | 278,762 (Direct) |
View |
| 2021-01-14 Sale(A) |
2021-07-19 9:02 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $43.99 | $2,419,344 | 436,330 (Direct) |
View |
| 2021-01-14 Sale |
2021-01-19 9:50 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $43.99 | $2,419,344 | 436,330 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 6:05 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
16,000 | $32.9 | $526,410 | 240,903 (Direct) |
View |
| 2020-08-31 Sale |
2020-09-01 5:13 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $27.05 | $135,250 | 256,903 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-02 Exercise |
2024-12-02 7:50 pm |
N/A 2030-09-03 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
2,500 | $0 | 29,127 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-02 7:50 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
2,500 | $29.55 | 29,127 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-17 6:20 pm |
N/A 2030-09-03 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
13,500 | $0 | 38,627 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-17 6:20 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
8,500 | $29.55 | 38,627 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-17 6:20 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
5,000 | $14.18 | 38,627 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 5:00 pm |
N/A 2034-06-17 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 9:02 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,658 | $0 | 435,802 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 9:02 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,658 | $3.3 | 435,802 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 8:30 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
18,600 | $0 | 390,877 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 8:30 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $15.5 | 390,877 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 8:30 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
13,600 | $3.3 | 390,877 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-15 8:30 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
1,400 | $0 | 368,727 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-15 8:30 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
1,400 | $3.3 | 368,727 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 9:00 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
20,000 | $0 | 410,877 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 9:00 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $15.5 | 410,877 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 9:00 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $3.3 | 410,877 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:02 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
100,000 | $0 | 329,402 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 8:01 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $0 | 265,605 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 8:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $1.01 | 265,605 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:06 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:15 pm |
N/A 2032-04-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
56,875 | $0 | 267,034 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 9:01 pm |
N/A 2029-04-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
30,000 | $0 | 327,459 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 9:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
30,000 | $15.5 | 327,459 (Direct) |
View |
| 2021-07-20 Exercise |
2021-07-22 9:01 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
17,400 | $0 | 325,103 (Direct) |
View |
| 2021-07-20 Exercise |
2021-07-22 9:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
17,400 | $1.01 | 325,103 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 9:02 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
4,600 | $0 | 278,762 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 9:02 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
4,600 | $1.01 | 278,762 (Direct) |
View |
| 2021-01-14 Exercise(A) |
2021-07-19 9:02 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $0 | 436,330 (Direct) |
View |
| 2021-01-14 Exercise(A) |
2021-07-19 9:02 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $1.01 | 436,330 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:50 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:20 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
85,415 | $0 | 261,409 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 9:50 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $0 | 436,330 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 9:50 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $1.01 | 436,330 (Direct) |
View |
| 2020-12-23 Exercise |
2020-12-28 9:01 pm |
N/A 2026-03-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
50,704 | $0 | 208,752 (Direct) |
View |
| 2020-12-23 Exercise |
2020-12-28 9:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
50,704 | $1.75 | 208,752 (Direct) |
View |
| 2020-12-11 Exercise |
2020-12-15 9:35 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
12,590 | $0 | 246,981 (Direct) |
View |
| 2020-12-11 Exercise |
2020-12-15 9:35 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
12,590 | $3.3 | 246,981 (Direct) |
View |
| 2020-10-14 Exercise |
2020-10-16 6:05 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
16,000 | $0 | 240,903 (Direct) |
View |
| 2020-10-14 Exercise |
2020-10-16 6:05 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
16,000 | $1.01 | 240,903 (Direct) |
View |
| 2020-09-04 Option Award |
2020-09-09 4:51 pm |
N/A 2030-09-03 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
40,127 | $0 | 40,127 (Direct) |
View |
| 2020-08-31 Exercise |
2020-09-01 5:13 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $0 | 256,903 (Direct) |
View |
| 2020-08-31 Exercise |
2020-09-01 5:13 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $1.01 | 256,903 (Direct) |
View |